Biopharma Stock Climbs on Drug Test Results: Today’s Canadian Small Cap Market Movers

Published:

Small
stocks making big moves on Friday, April 17, 2015 (as of 4 pm EST), as
reported by Sean Mason, SmallCapPower.com

Antibe Therapeutics Inc. (TSXV:
ATE
) shares powered 38% higher to $0.22 on Friday after the developer of medicines
for pain and inflammation announced the results of additional testing of the in
vivo activity of its lead anti-inflammatory drug, ATB-346, which support the company’s
earlier communication that ATB-346 may be effective at much lower doses than
previously expected, and that once daily dosing may be effective.

As well,
shares of DATA Group Ltd. (TSX:
DGI
) slid 1.3% to $0.75 as the managed business communications services
company said that Michael Suksi has stepped down as the company’s President and
Chief Executive Officer and is being replaced by Michael Sifton, former President
and CEO of Sun Media.  

Foran Mining Corporation (TSXV:
FOM
), meanwhile, reported results of the second hole completed in the
winter 2015 exploration program at the Bigstone deposit, on its 100% owned
Bigstone property in Saskatchewan, which included 2.03% copper over 104.94 metres.
Foran Mining stock fell 26% to $0.355 following the announcement.  

Related articles

Recent articles